What has universal leucodepletion given us: Evidence from clinical trials?

Vox Sanguinis, Supplement

Volumn 87, Issue 2, 2004, Pages

  Van De Watering, Leo ^a  

^a Sanquin Bloedbank Regio Zuidwest Rotterdam   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOIMMUNIZATION; BLOOD FILTRATION; BLOOD TRANSFUSION; BLOOD TRANSFUSION REACTION; CONFERENCE PAPER; DISEASE TRANSMISSION; GRAFT VERSUS HOST REACTION; HOSPITALIZATION; HUMAN; LEUKOPENIA; PRIORITY JOURNAL; SURGICAL MORTALITY; UNITED KINGDOM;

BLOOD TRANSFUSION; CLINICAL TRIALS; GRAFT VS HOST DISEASE; HUMANS; LEUKAPHERESIS; LEUKOCYTE COUNT; LEUKOCYTES; POSTOPERATIVE COMPLICATIONS; PRION DISEASES;

EID: 4444331867     PISSN: 17416892     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (28)

1. Claas FH, Smeenk RJ, Schmidt R, van Steenbrugge GJ, Eernisse JG: Alloimmunization against the MHC antigens after platelet transfusions is due to contaminating leukocytes in the platelet suspension. Exp Hematol 1981; 9:84-9
2. Sniecinski I, O'Donnell MR, Nowicki B, Hill LR: Prevention of refractoriness and HLA-alloimmunization using filtered blood products. Blood 1988; 71:1402-7
3. Andreu G, Dewailly J, Leberre C, Quarre MC, Bidet ML, Tardivel R, Devers L, Lam Y, Soreau E, Boccaccio C: Prevention of HLA immunization with leukocyte-poor packed red cells and platelet concentrates obtained by filtration. Blood 1988; 72:964-9
4. Novotny VM, van Doorn R, Witvliet MD, Claas FH, Brand A: Occurrence of allogeneic HLA and non-HLA antibodies after transfusion of prestorage filtered platelets and red blood cells: A prospective study. Blood 1995; 85:1736-41
5. Kao KJ, Mickel M, Braine HG, Davis K, Enright H, Gernsheimer T, Gillespie MJ, Kickler TS, Lee EJ, McCullough JJ: White cell reduction in platelet concentrates and packed red cells by filtration: A multicenter clinical trial. The Trap Study Group. Transfusion 1995; 35:13-9
6. Vamvakas EC: Meta-analysis of randomized controlled trials of the efficacy of white cell reduction in preventing HLA-alloimmunization and refractoriness to random-donor platelet transfusions. Transfus Med Rev 1998; 12:258-70
7. Jensen LS, Andersen AJ, Christiansen PM, Hokland P, Juhl CO, Madsen G, Mortensen J, Moller-Nielsen C, Hanberg-Sorensen F, Hokland M: Postoperative infection and natural killer cell function following blood transfusion in patients undergoing elective colorectal surgery. Br J Surg 1992; 79:513-6
8. Jensen LS, Kissmeyer-Nielsen P, Wolff B, Qvist N: Randomised comparison of leucocyte-depleted versus buffy-coat-poor blood transfusion and complications after colorectal surgery. Lancet 1996; 348:841-5
9. van de Watering LM, Hermans J, Houbiers JG, van den Broek PJ, Bouter H, Boer F, Harvey MS, Huysmans HA, Brand A: Beneficial effects of leukocyte depletion of transfused blood on post-operative complications in patients undergoing cardiac surgery: A randomized clinical trial. Circulation 1998; 97:562-8
10. Tartter PI, Mohandas K, Azar P, Endres J, Kaplan J, Spivack M: Randomized trial comparing packed red cell blood transfusion with and without leukocyte depletion for gastrointestinal surgery. Am J Surg 1998; 176:462-6
11. Bilgin YM, van de Watering LM, Lorinser JE, Versteegh MIM, Eijsman L, van Oers MH, Brand A: Leukocyte-depletion in cardiac surgery lowers postoperative infections but not multiple-organ-dysfunction syndrome: Results of a clinical study. Vox Sang 2002; 83:225a
12. Bilgin YM, van de Watering LM, Lorinser JE, Versteegh MIM, Eijsman L, van Oers MH, Brand A: The effects of prestorage leukocyte-depletion of erytrocyte concentrates in cardiac surgery: A double-blind randomised clinical trial. Blood 2001; 98:828a-9a
13. Blajchman MA, Dzik S, Vamvakas EC, Sweeney J, Snyder EL: Clinical and molecular basis of transfusion-induced immuno-modulation: Summary of the proceedings of a state-of-the-art conference. Transfus Med Rev 2001; 15:108-35
14. Sirchia G, Wenz B, Rebulla P, Parravicini A, Camelli V, Bertolini F: Removal of white cells from red cells by transfusion through a new filter. Transfusion 1990; 30:30-3
15. Heddle NM, Klama LN, Griffith L, Roberts R, Shukla G, Kelton JG: A prospective study to identify the risk factors associated with acute reactions to platelet and red cell transfusions. Transfusion 1993; 33:794-7
16. Dzik WH, Jones KS: The effects of gamma irradiation versus white cell reduction on the mixed lymphocyte reaction. Transfusion 1993; 33:493-6
17. Anonymous: Serious Hazards of Transfusion, Annual Report 2000-2001 2002; http://www.shotuk.org/SHOT%20Report%2000-O1.pdf (date of accession December 2003)
18. Jensen LS, Grunnet N, Hanberg-Sorensen F, Jorgensen J: Cost-effectiveness of blood transfusion and white cell reduction in elective colorectal surgery. Transfusion 1995; 35:719-22
19. Buchholz DH, AuBuchon JP, Snyder EL, Kandler R, Edberg S, Piscitelli V, Pickard C, Napychank P: Removal of Yersinia enterocolitica from AS-1 red cells. Transfusion 1992; 32:667-72
20. Bowden RA, Slichter SJ, Sayers M, Weisdorf D, Cays M, Schoch G, Banaji M, Haake R, Welk K, Fisher L: A comparison of filtered leukocyte-reduced and cytomegalovirus (CMV) seronegative blood products for the prevention of transfusion-associated CMV infection after marrow transplant. Blood 1995; 86:3598-603
21. Krailadsiri P, Perry R, Drummond O, Smith K, Hockley D, Seghatchian J, Spring F, Macgregor I, Williamson L, Prowse C, Lubenko A, Anstee D, Barrowcliffe T, Turner M: The effects of leucocyte depletion on the generation and removal of micro-vesicles and prion related protein in blood components. Transfus Apheresis Sci 2001; 25:177-8
22. van de Watering LM, Hermans J, Witvliet M, Versteegh MIM, Brand A: HLA and red cell immunization after filtered and buffy-coat depleted blood transfusion in cardiac surgery: A randomized controlled trial. Transfusion 2003; 43:765-71
23. Houbiers JG, Brand A, van de Watering LM, Hermans J, Verwey PJ, Bijnen AB, Pahlplatz P, Eeftinck Schattenkerk M, Wobbes T, de Vries JE, Klementschitsch P, van de Maas AH, van de Velde CJ: Randomised controlled trial comparing transfusion of leucocyte-depleted or buffy-coat-depleted blood in surgery for colorectal cancer. Lancet 1994; 344:573-8
24. Dzik WH, Anderson JK, O'Neill EM, Assmann SF, Kalish LA, Stowell CP: A prospective, randomized clinical trial of universal WBC reduction. Transfusion 2002; 42:1114-22
25. Baron JF, Gourdin M, Bertrand M, Mercadier A, Deloit J, Kieffer E, Coriat P: The effect of universal leukodepletion of packed red blood cells on postoperative infections in high-risk patients undergoing abdominal aortic surgery. Anesth Analg 2002; 94:529-37
26. Ibojie J, Greiss MA, Urbaniak SJ: Limited efficacy of universal leucodepletion in reducing the incidence of febrile nonhaemolytic reactions in red cell transfusions. Transfus Med 2002; 12:181-5
27. Uhlmann EJ, Isgriggs E, Wallhermfechtel M, Goodnough LT: Prestorage universal WBC reduction of RBC units does not affect the incidence of transfusion reactions. Transfusion 2001; 41:997-1000
28. Sackett DL: Rules of evidence and clinical recommendations on the use of antithrombotic agents. Chest 1989; 95 (2 Suppl): 25-45